Featured Post

Heart failure is the number one cause of hospitalization in people over 65 and projected to rise 50% across the next 25 years. The 5 year mortality rate for patients with HF is 43%. HF diagnosis is often missed in primary care. Point-of-care testing using AI echo and NT-proBNP could democratize HF screening beyond hospital…

Us2.ai, a leader in AI-automated echocardiography solutions and Advara HeartCare, the largest provider of cardiac healthcare services in Australia, are excited to announce a pilot aimed at enhancing heart disease detection, diagnosis and treatment. This pilot brings Us2.ai’s cutting-edge AI automated echocardiography solution to TickerCardiology, Advara HeartCare’s echocardiogram PACS software, to enhance the delivery of…

New research using Us2.ai in comparison to gold standard invasive hemodynamic measurement showed that in patients with HFpEF, AI measurements of echo parameters are interchangeable with manual core-lab measures to diagnose increased filling pressures. “Evaluation of left ventricular filling pressures using non-invasive techniques is the holy grail of cardiac imaging in the setting of heart…

Singapore – April 5, 2024 — Us2.ai, a leading MedTech firm backed by prominent investors including IHH Healthcare, Heal Partners, Peak XV Partners (formerly Sequoia India) and EDBI announces FDA clearance for Us2.v2, featuring 45 automated echo parameters, including strain analysis [1], marking a significant stride in medical innovation. Us2.v2 is an advanced image post-processing…

Each year, RHD kills nearly 400,000 people globally. Experts at Children’s National Hospital deployed algorithms on the Us2.ai platform to detect early-stage RHD with the same accuracy as a cardiologist. “AI will tell you to move (the probe) left or right to get the ideal picture… Even more importantly, we’ve developed technology that can tell…